Krish Krishnan, Krystal Biotech CEO
Dermatology biotech Krystal settles lawsuit from former partner as it prepares first FDA pitch
Krystal Biotech’s legal troubles with a small partner are over.
The Pittsburgh company settled its trade secrets dispute with PeriphaGen on Tuesday, agreeing to pay …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.